| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/19/2001 | WO2001027131A1 Purine derivatives |
| 04/19/2001 | WO2001027119A2 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines |
| 04/19/2001 | WO2001027114A1 PYRROLO[2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
| 04/19/2001 | WO2001027109A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | WO2001027103A1 Fab i inhibitors |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027079A2 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | WO2001027070A1 Use of carbonylamino derivatives against cns disorders |
| 04/19/2001 | WO2001026683A2 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026680A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/19/2001 | WO2001026663A1 Extended release formulations of erythromycin derivatives |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2001026654A1 Fab i inhibitors |
| 04/19/2001 | WO2001026652A1 Fab i inhibitors |
| 04/19/2001 | WO2001026648A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 04/19/2001 | WO2001026627A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2001001963A8 A method for the improvement of transport across adaptable semi-permeable barriers |
| 04/19/2001 | WO2000071078A3 Composition designed for implementing an antitumoral or antiviral treatment in a mammal |
| 04/19/2001 | WO2000070086A9 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000055621A3 Blood leucocyte apheresis for treatment of disease |
| 04/19/2001 | WO2000032047A9 Plasmid maintenance system for antigen delivery |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | WO1999051188A3 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 04/19/2001 | WO1999032448A8 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 04/19/2001 | DE19948417A1 Imidazol-Derivate und ihre Verwendung als Arzneimittel Imidazole derivatives and their use as medicaments |
| 04/19/2001 | CA2389652A1 Archaeosomes as immunomodulating carriers for acellular vaccines to induce cytotoxic t lymphocyte(ctl) responses and protect the vaccinated host against intracellular pathogens and cancer |
| 04/19/2001 | CA2388991A1 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2388232A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | CA2388224A1 Novel c-type lectin and gene thereof |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387626A1 Viral particles with exogenous internal epitopes |
| 04/19/2001 | CA2387621A1 Extended release formulations of erythromycin derivatives |
| 04/19/2001 | CA2387604A1 Peptides which stimulate the immune response and tissue regeneration |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387145A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | CA2387063A1 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/19/2001 | CA2386804A1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | CA2385784A1 Antimicrobial compositions comprising multidrug efflux pumps |
| 04/19/2001 | CA2385172A1 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/19/2001 | CA2381297A1 Pyrrolo¬2,3-d|pyrimidine nucleoside analogs |
| 04/18/2001 | EP1092779A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/18/2001 | EP1092774A2 Borrelia burgdorferi antigen OspA, gene encoding it and uses thereof |
| 04/18/2001 | EP1092765A2 Germination-activated red Ganoderma lucidum spores and method for producing the same |
| 04/18/2001 | EP1092439A1 Activation of antigen-specific T cells by virus/antigen-treated dendritic cells |
| 04/18/2001 | EP1092437A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 04/18/2001 | EP1092040A2 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 04/18/2001 | EP1092035A2 Targeted integration into chromosomes using retroviral vectors |
| 04/18/2001 | EP1092013A1 3'-exonuclease, production and use thereof |
| 04/18/2001 | EP1091975A1 Novel cyclosporin with improved activity profile |
| 04/18/2001 | EP1091974A2 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 04/18/2001 | EP1091971A2 Polyketides and their synthesis |
| 04/18/2001 | EP1091957A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria |
| 04/18/2001 | EP1091944A1 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 04/18/2001 | EP1091939A1 Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors |
| 04/18/2001 | EP1091774A1 Bone cement with antimicrobial peptides |
| 04/18/2001 | EP1091763A2 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters |
| 04/18/2001 | EP1091757A2 Alpha emitting constructs and uses thereof |
| 04/18/2001 | EP1091756A2 Haemophilus parasuis vaccine and diagnostic |
| 04/18/2001 | EP1091753A1 Antiproliferative and antiviral proteins and peptides |
| 04/18/2001 | EP1091752A1 Compositions comprising endotoxin neutralizing protein and derivatives and uses thereof |
| 04/18/2001 | EP1091748A2 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation |
| 04/18/2001 | EP1091736A1 Inhibitors of prenyl-protein transferase |
| 04/18/2001 | EP1091726A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 04/18/2001 | EP0935462A4 Photopheresis treatment of leukocytes |
| 04/18/2001 | EP0915823B1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 04/18/2001 | EP0731697B1 Ssi tyrphostins and pharmaceutical compositions |
| 04/18/2001 | EP0682663B1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b]pyran-2-ones useful to treat retroviral infections |
| 04/18/2001 | EP0576478B2 Herpes simplex vaccine comprising hsv glycoprotein gd and 3 deacylated monophosphoryl lipid a |
| 04/18/2001 | CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/18/2001 | CN1291993A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 04/18/2001 | CN1291988A Novel aromatic amides, preparation method and application as medicines |
| 04/18/2001 | CN1291980A thioether furan nitrone compounds |
| 04/18/2001 | CN1291975A Process for preparing protected 4-aminomethyl-pyrrolidin-3-one |
| 04/18/2001 | CN1291899A Live recombined vaccines injected with adjuvant |
| 04/18/2001 | CN1291897A Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 04/18/2001 | CN1291895A Polymeric compounds and methods of formulating same |
| 04/18/2001 | CN1291862A Fungicide composition comprising benzoylphenylurea |
| 04/18/2001 | CN1291615A 2', 3'-O-isopropylidennucleoside 5'-thiophosphamino acid ester compound |
| 04/18/2001 | CN1291612A Cynnematin kind antibiotics |
| 04/18/2001 | CN1291611A Cynnematin kind antibiotics |
| 04/18/2001 | CN1291610A Triazole derivative possessing anti-fungus activity |
| 04/18/2001 | CN1291490A Process for preparing medicine 'Bingduxiao' |
| 04/18/2001 | CN1291488A Ningxueling capsule |
| 04/18/2001 | CN1064685C Tetrahydrofuran antifungals |
| 04/18/2001 | CN1064537C Skin absorptive antiviral drug acyclovir |
| 04/18/2001 | CA2321437A1 Dna encoding structural protein-1 of infectious salmon anaemia virus and uses thereof |
| 04/17/2001 | US6218537 Process for making pyridyl and pyrimidine substituted imidazole compounds |
| 04/17/2001 | US6218528 MurB |
| 04/17/2001 | US6218511 Anti-apoptotic genes of human cytomegalovirus (HCMV) and their use |
| 04/17/2001 | US6218438 N-aroyl hydrazone poly(oxyethylene)-poly(oxypropylene) nonionic block copolymer; hiv |
| 04/17/2001 | US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal |
| 04/17/2001 | US6218413 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |